All Type of News
Boryung wins patent nullification trial over oxaliplatin
Boryung Pharm won the right to market a liquid form of oxaliplatin for cancer.
The company announced on June 4 that it secured the right to sell a generic version of Sanofi-Aventis’s Eloxatin on the Korean market a...
Daewoong’s Easyef having nonproprietary name
Daewoong Pharm says its biodrug Easyef (ingredient: EGF) obtained an International Nonproprietary Name (INN) “Nepidermin,” which has been officially designated by the World Health Organization.
INN facilitates the ...
Restriction targets cold medicine
The government plans to restrict sales of cold medications containing a substance often used in the illegal manufacture of methamphetamine, according to the Korea Food and Drug Administration.
Pseudoephedrine, a ma...
Lip care products to vie for pharmacy market
As the country's two lip care forerunners – Nivea and Wyeth, are poised to kick off sales of early this month, other domestic lip care makers will be rushing into the game by the next week selling their wares at pharm...
Yooyoung to introduce Nippon Shinyaku’s NS-126Yooyoung Pharm and Nippon Shinyaku Co. have recently announced an exclusive license agreement, under which Yooyoung will acquire exclusive rights in Korea to develop and commerc...
|
Health insurance covers 10 medicines only since introduction of positive list system
The government has asked the national health insurance to cover 10 medicines to reduce snowballing medication costs since implementation of the positive list system, triggering mounting concerns among drug makers.
...
Positive list system re-emerging as contentious issueThe government is firm in pushing for drug pricing reform, which it says cannot be the subject of transparency as it is part of the country's healthcare policies that ensure the...
|
Korean drug makers fared well in ethical sales
The nation’s major pharmaceutical firms, including Daewoong Pharm and Hanmi Pharm, increased their share of the pie in the domestic ethical market last year, according to EDI claims tallied by the Health Insurance Rev...
Wholesalers need to brace fair trade
Despite their efforts for advanced logistics these days, domestic drug wholesalers have been urged to ensure fair trade as a number of pharmaceutical firms are poised to reduce wholesaler margin in order to compensate...
Akreos MI60 to be available in KoreaBausch & Lomb Korea, the Korean unit of Bausch & Lomb, says it has received a marketing approval of its Akreos AO Micro Incision Intraocular Lens (Akreos MI60).
In keeping wi...
|
